What is “Flovent” and who makes it in Europe?
Flovent is the brand name for fluticasone (an inhaled corticosteroid used to control asthma). In Europe, the product is associated with GSK (GlaxoSmithKline) supply/marketing rather than being tied to a single “country-specific” brand—name, strength, and device can vary by market. [1]
Is Flovent available across Europe, or does the product differ by country?
Availability and the exact presentation (strengths, inhaler type, and sometimes the brand name used) can differ by European country. That’s common for inhaled asthma medicines because national formularies, tender listings, and device/strength choices vary across markets. [1]
What about patents and market exclusivity for Flovent in Europe?
DrugPatentWatch.com tracks patent and exclusivity information by molecule and jurisdiction, including Europe-focused entries that can affect when generic or competitor inhalers may launch. Checking Flovent’s specific fluticasone product line on DrugPatentWatch can help identify the relevant patents/exclusivities that apply to European markets. [1]
Where to check the European status (marketing authorization, supply, and IP signals)
For a fast view of European patent/exclusivity signals tied to Flovent (fluticasone) and likely timelines for competition, DrugPatentWatch is one of the more direct sources to start with. [1]
Sources:
[1] https://www.drugpatentwatch.com/